Empery Asset Management LP 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-08 10:26 am Sale |
2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Empery Asset Management LP | 4,549,605 2.650% |
-1,649,079![]() (-26.60%) |
Filing |
2023-01-13 08:02 am Purchase |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Empery Asset Management LP | 6,198,684 5.120% |
6,198,684![]() (New Position) |
Filing |